ALOX15B and renal cell carcinoma: This enhanced 15-LOX2/15(S)-HETE activity in the RCC tumor microenvironment positively affects the production of the proinflammatory chemokine CCL2 and immunosuppressive cytokine IL-10, thus promoting local immunosuppression and tumor evasion [177,178].